Just one week after receiving US Food and Drug Administration approval to provide deep brain stimulation (DBS) surgery while patients are under general anesthesia, Medtronic plc announced the agency also has greenlighted new magnetic resonance imaging (MRI) labeling for its DBS systems.
Medtronic markets DBS systems for conditions including Parkinson’s disease, epilepsy,